Announcements Trials

Browse Landscape

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

fludarabine phosphate 5 Cyclophosphamide 5 Azacitidine 4 Thiotepa 3 Stem Cell Transplantation 3 Melphalan 3 Gemtuzumab 3 Decitabine 3 Cytarabine 3 Busulfan 3 venetoclax 2 Radiotherapy 2 Methylprednisolone 2 Interferon alpha-2 2 Injections 2 Filgrastim 2 Etoposide 2 Emapalumab 2 Cyclosporine 2 Cladribine 2 Antilymphocyte Serum 2 vosaroxin 1 vedolizumab 1 trametinib 1 tipifarnib 1 thymoglobulin 1 peginterferon alfa-2b 1 peginterferon alfa-2a 1 nilotinib 1 midostaurin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Hydroxychloroquine × Myeloid × Clear all

NCT05084872 2021-10-20

HCQMa

University Hospital, Toulouse

Phase 2/3 Unknown

Mastocytosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡